1262860-72-9

Basic information

• Product Name: 3-Chloro-5-difluoroMethoxy-pyridine-2-carboxylic acid
• Synonyms: 3-Chloro-5-difluoroMethoxy-pyridine-2-carboxylic acid;3-chloro-5-(difluoroMethoxy)picolinic acid
• CAS NO: 1262860-72-9
• Molecular Formula: C7H4ClF2NO3
• Molecular Weight: 223.5613664
• Mol File: 1262860-72-9.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-Chloro-5-difluoroMethoxy-pyridine-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Chloro-5-difluoroMethoxy-pyridine-2-carboxylic acid(1262860-72-9)
• EPA Substance Registry System: 3-Chloro-5-difluoroMethoxy-pyridine-2-carboxylic acid(1262860-72-9)

Safety Data

• Hazardous Substances Data: 1262860-72-9(Hazardous Substances Data)

Usage

General Description

3-Chloro-5-difluoroMethoxy-pyridine-2-carboxylic acid is a chemical compound with a molecular structure that consists of a pyridine ring substituted with a chlorine atom, two fluorine atoms, a methoxy group, and a carboxylic acid group. It is a highly reactive compound and is commonly used as a building block in the synthesis of various pharmaceuticals and agrochemicals. The presence of the carboxylic acid group makes it a versatile intermediate for the formation of derivatives and analogs. It is also used in the development of new drugs and as a precursor for the synthesis of complex organic compounds. Due to its diverse applications, this chemical is of significant interest to researchers in the fields of medicinal chemistry and drug discovery.

Upstream product

• 98121-41-6 5-Amino-2,3-dichloropyridine 
• 1262860-73-0 3-chloro-5-(difluoromethoxy)pyridine-2-carbonitrile 
• 110861-18-2 5-acetoxy-2,3-dichloropyridine 
• 1262860-70-7 3-chloro-5-hydroxy-pyridine-2-carbonitrile 

Relevant articles and documents

N-[2-(3-AMINO-2,5-DIMETHYL-1,1-DIOXIDO-5,6-DIHYDRO-2H-1,2,4-THIADIAZIN-5-YL)-1,3-THIAZOL-4-YL] AMIDES USEFUL AS BACE INHIBITORS

The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2 and R3/su

TETRAHYDROPYRANO[3,4-D][1,3]OXAZIN DERIVATIVES AND THEIR USE AS BACE INHIBITORS

The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula (I), wherein the variables R1, R2, R3, R4 and X are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Oxazine Derivatives and their Use in the Treatment of Neurological Disorders

The invention relates to novel heterocyclic compounds of the formula in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their medical use and to medicaments comprising them.